PRONTO-PEDS will test if a ultra-fast insulin product given before or immediately after meals improves glycemic control in children and teens with type 1 diabetes.
New study aims to design future interventions to enhance cancer survivors’ well-being and appropriate healthcare utilization throughout their lifetime.